The generic medicines sector is large and dynamic with several ongoing challenges and issues. Expired patents for blockbuster drugs and increasing healthcare expenditure will continue to drive the growth of the industry.
Related articles:
Actavis expands in Iceland
Generic medicines - a pressing issue
Swedish generics gaining ground in Europe
Legal aspects of the pharmaceutical and generics industry - protect your "Return on Innovation"
